MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced ...
Agiliti (AGTI) shares rallied 5.5% in the last trading session to close at $20.02. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session ...
Agiliti (AGTI) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.30 per share a year ago. These figures are ...
Agiliti serves more than 10,000 national, regional and local acute care and alternate site providers across the U.S. For more than eight decades, Agiliti has delivered medical device management and ...
The medical equipment and supplies company owns or manages more than 1.2 million units of medical equipment for more than 7,000 national, regional, and local acute care hospitals in the U.S. On Monday ...
Agiliti, Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the United States healthcare industry, today announced that Tom Leonard will ...
MINNEAPOLIS--(BUSINESS WIRE)--Agiliti, a nationwide manufacturer and provider of medical device solutions to the healthcare industry, today announced the launch of its Adapt Line™ of therapeutic ...
One-of-a-kind technology enhances care for patients across surgical, perioperative and emergency care environments Agiliti, a leading manufacturer and provider of medical device solutions to the U.S.
(1) Management and other expenses represent (a) management fees and buyout termination fee under the Advisory Services Agreement, which was terminated in connection with the initial public offering ...
Agiliti Shareholders to Receive $10.00 per Share in Cash, Representing Premia of 39% and 43% Over Agiliti’s 30-Day and 90-Day Volume Weighted Average Price The purchase price represents premia of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results